ArticleCardiovascular diabetology2025

Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide registry-based cohort study.

Yiran Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.